Renin-angiotensin system in the central nervous system: focus on Huntington's disease

被引:1
|
作者
de Miranda, Aline Silva [1 ,2 ]
Teixeira, Antonio Lucio [3 ,4 ]
机构
[1] Univ Fed Minas Gerais UFMG, Inst Ciencias Biol, Dept Morfol, Lab Neurobiol, Belo Horizonte, MG, Brazil
[2] Univ Fed Minas Gerais UFMG, Lab Interdisciplinar Invest Med LIIM, Fac Med, Belo Horizonte, MG, Brazil
[3] Univ Texas Hlth Sci Ctr Houston, Neuropsychiat Program, Dept Psychiat & Behav Sci, McGovern Med Sch, Houston, TX 77030 USA
[4] Fac Santa Casa BH, Belo Horizonte, MG, Brazil
关键词
INHIBITOR;
D O I
10.4103/1673-5374.368301
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
引用
收藏
页码:2206 / 2207
页数:2
相关论文
共 50 条
  • [21] The Counter Regulatory Axis of the Lung Renin-Angiotensin System in Severe COVID-19: Pathophysiology and Clinical Implications
    Triposkiadis, Filippos
    Starling, Randall C.
    Xanthopoulos, Andrew
    Butler, Javed
    Boudoulas, Harisios
    HEART LUNG AND CIRCULATION, 2021, 30 (06) : 786 - 794
  • [22] CHRONIC TREATMENT WITH A SGLT2 INHIBITOR DOES NOT ACTIVATE SYSTEMIC AND INTRARENAL RENIN-ANGIOTENSIN SYSTEM IN CKD RATS
    Lei, Li
    Nakano, Daisuke
    Hitomi, Hirofumi
    Nishiyama, Akira
    JOURNAL OF HYPERTENSION, 2018, 36 : E18 - E18
  • [23] Renin-Angiotensin System Blockers May Create More Risk Than Reward for Sodium-Depleted Cardiovascular Patients With High Plasma Renin Levels
    Sealey, Jean E.
    Alderman, Michael H.
    Furberg, Curt D.
    Laragh, John H.
    AMERICAN JOURNAL OF HYPERTENSION, 2013, 26 (06) : 727 - 738
  • [24] Role of poly (ADP-ribose)-polymerase and its signaling pathway with renin-angiotensin aldosterone system in renal diseases
    Zhou, Tian-Biao
    Jiang, Zong-Pei
    JOURNAL OF RECEPTORS AND SIGNAL TRANSDUCTION, 2014, 34 (03) : 143 - 148
  • [25] Pharmacokinetics of Agelastatin A in the central nervous system
    Li, Zhimin
    Kamon, Takuma
    Personett, David A.
    Caulfield, Thomas
    Copland, John A.
    Yoshimitsu, Takehiko
    Tun, Han W.
    MEDCHEMCOMM, 2012, 3 (02) : 233 - 237
  • [26] Effects of inhibitors of the renin-angiotensin system on reducing blood pressure and expression of inflammatory factors in CHD patients: A network meta-analysis
    Pang, Xue-Feng
    Liu, Run-Mei
    Xia, Yun-Feng
    JOURNAL OF CELLULAR PHYSIOLOGY, 2019, 234 (05) : 5988 - 5997
  • [27] Complement Activation in the Central Nervous System: A Biophysical Model for Immune Dysregulation in the Disease State
    Peoples, Nicholas
    Strang, Candace
    FRONTIERS IN MOLECULAR NEUROSCIENCE, 2021, 14
  • [28] The emerging roles of ferroptosis in cells of the central nervous system
    Li, Yuyao
    Xiao, Dongqiong
    Wang, Xiaodong
    FRONTIERS IN NEUROSCIENCE, 2022, 16
  • [29] Pathogenesis of central nervous system germ cell tumors
    Liu, Siyuan
    Ren, Linan
    Gao, Xue
    Hao, Mengjin
    Wang, Guixia
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [30] The effects of dapagliflozin on cardio-renal risk factors in patients with type 2 diabetes with or without renin-angiotensin system inhibitor treatment: a post hoc analysis
    Scholtes, Rosalie A.
    van Raalte, Daniel H.
    Correa-Rotter, Ricardo
    Toto, Robert D.
    Heerspink, Hiddo J. L.
    Cain, Valerie
    Sjostrom, C. David
    Sartipy, Peter
    Stefansson, Bergur, V
    DIABETES OBESITY & METABOLISM, 2020, 22 (04) : 549 - 556